Arsanis, Inc. (92) | Stock Agreements (2)
- Common Stock Purchase Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 16, 2020)
- Form of Common Stock Certificate (Filed With SEC on March 13, 2019)
